Q4 2024 · 13F-HR
a16z Capital Management, L.L.C.holdings as filed
Filed 2025-02-12 · accession 0001104659-25-012178
$745.3M
Reported value
12
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 25809K105 | DASH | DOORDASH INC | $267.9M | 35.9% | 1,597,010 | Common | SOLE |
| 79589L106 | IOT | SAMSARA INC | $174.6M | 23.4% | 3,995,652 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $120.2M | 16.1% | 2,748,523 | Common | SOLE |
| 852234103 | XYZ | BLOCK INC | $86.4M | 11.6% | 1,016,697 | Common | SOLE |
| 63909J108 | NAUT | NAUTILUS BIOTECHNOLOGY INC | $29.7M | 3.98% | 17,653,917 | Common | SOLE |
| 09077V100 | BIOA | BIOAGE LABS INC | $18.7M | 2.51% | 3,233,170 | Common | SOLE |
| 00437E102 | ACCDUSD | ACCOLADE INC | $18.5M | 2.48% | 5,398,708 | Common | SOLE |
| 13463J101 | CAMP | CAMP4 THERAPEUTICS CORP | $11.1M | 1.49% | 2,125,339 | Common | SOLE |
| 683712103 | OPEN | OPENDOOR TECHNOLOGIES INC | $9.9M | 1.33% | 6,200,821 | Common | SOLE |
| 29479A108 | ERAS | ERASCA INC | $7.2M | 0.96% | 2,862,500 | Common | SOLE |
| 37611X209 | DNA | GINKGO BIOWORKS HOLDINGS INC | $1.1M | 0.14% | 108,568 | Common | SOLE |
| 23257B206 | — | CYNGN INC | $48,895 | 0.01% | 57,584 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.